Brent Kendrick

He received his B.S in Aerospace Engineering and his Ph.D. in Pharmaceutical Sciences from the University of Colorado. Prior to graduate school, Brent served in the United States Navy as a Surface Warfare Officer. He joined Amgen, Inc. in 1997, and held positions of increasing responsibility throughout his tenure in Formulation Development, Quality Control, Analytical Sciences and Process Development. Prior to leaving Amgen, he was Director of Amgen’s Attribute Sciences for Late Stage Clinical and Commercial Products, leading a team of over 100 staff and multiple sites worldwide. He has been an adjoint and adjunct faculty member at the University of Colorado for over 20 years, teaching light scattering biophysics. He taught a semester-long 3 credit hour course on Heat Transfer in the CU Chemical Engineering Department in 2015. In 2015 he co-founded Elion, LLC, a contract analytical and formulations laboratory for biotechnology product development and served as Chief Scientific Officer. In 2018 he sold Elion, LLC to KBI Biopharma, where served as Vice President, Research and Development until 2020, where he founded First Principles Biopharma, LLC.